Critical Care

official impact factor 4.60

Anticoagulant properties of drotrecogin alfa (activated) during hemofiltration in patients with severe sepsis

Anne CJM de Pont* and Marcus J Schultz

Critical Care 2009, 13:113 doi:10.1186/cc7684

Accesses  

  • Last 30 days: 36 accesses
  • Last year: 437 accesses
  • All time: 1563 accesses

Cited by

BioMed Central: 1 citation

Review   Free Highly Accessed

Year in review 2008: Critical Care - nephrology

Zaccaria Ricci, Claudio Ronco Critical Care 2009, 13:227 (21 October 2009)